SGHT Profile
Sight Sciences, Inc., an ophthalmic medical device company, focuses on developing and commercializing innovative surgical and nonsurgical technologies for treating eye diseases. The company's product portfolio includes the OMNI Surgical System, a therapeutic device designed to reduce intraocular pressure in adult glaucoma patients, and the TearCare System, a wearable eyelid technology aimed at treating dry eye disease (DED) for use by ophthalmologists and optometrists. Founded in 2010, Sight Sciences is headquartered in Menlo Park, California, and is dedicated to advancing eye care through technological innovation.
The OMNI Surgical System integrates two distinct surgical procedures into one device, enabling ophthalmic surgeons to perform canaloplasty and trabeculotomy through a single corneal incision. This dual-functionality simplifies the surgical process, potentially reducing complications and improving outcomes for glaucoma patients. The OMNI System is designed to be a minimally invasive solution, providing an alternative to more invasive surgical options and thereby expanding treatment possibilities for patients with varying degrees of glaucoma.
The TearCare System addresses the underlying causes of dry eye disease by delivering targeted thermal energy to the meibomian glands in the eyelids. This therapy helps to liquefy and express the gland's contents, promoting the natural production of oils necessary for a healthy tear film. The wearable nature of TearCare allows for precise application and greater patient comfort, distinguishing it from other treatments on the market. This innovative approach aims to provide long-term relief for patients suffering from chronic dry eye disease.
Sight Sciences distributes its products through a network of sales representatives and distributors, reaching hospitals, medical centers, and eye care professionals across the United States. By collaborating with leading ophthalmologists and optometrists, the company ensures that its technologies meet the highest standards of clinical efficacy and patient safety. Sight Sciences' commitment to research and development, coupled with its strategic market approach, positions it as a key player in the ophthalmic medical device industry, dedicated to improving patient outcomes through cutting-edge technology.
|
